Correlation Between Elevation Oncology and X4 Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Elevation Oncology and X4 Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Elevation Oncology and X4 Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Elevation Oncology and X4 Pharmaceuticals, you can compare the effects of market volatilities on Elevation Oncology and X4 Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Elevation Oncology with a short position of X4 Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Elevation Oncology and X4 Pharmaceuticals.
Diversification Opportunities for Elevation Oncology and X4 Pharmaceuticals
0.26 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Elevation and XFOR is 0.26. Overlapping area represents the amount of risk that can be diversified away by holding Elevation Oncology and X4 Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on X4 Pharmaceuticals and Elevation Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Elevation Oncology are associated (or correlated) with X4 Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of X4 Pharmaceuticals has no effect on the direction of Elevation Oncology i.e., Elevation Oncology and X4 Pharmaceuticals go up and down completely randomly.
Pair Corralation between Elevation Oncology and X4 Pharmaceuticals
Given the investment horizon of 90 days Elevation Oncology is expected to generate 2.35 times less return on investment than X4 Pharmaceuticals. But when comparing it to its historical volatility, Elevation Oncology is 2.21 times less risky than X4 Pharmaceuticals. It trades about 0.09 of its potential returns per unit of risk. X4 Pharmaceuticals is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest 53.00 in X4 Pharmaceuticals on November 2, 2024 and sell it today you would earn a total of 13.00 from holding X4 Pharmaceuticals or generate 24.53% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Elevation Oncology vs. X4 Pharmaceuticals
Performance |
| Timeline |
| Elevation Oncology |
| X4 Pharmaceuticals |
Elevation Oncology and X4 Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Elevation Oncology and X4 Pharmaceuticals
The main advantage of trading using opposite Elevation Oncology and X4 Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Elevation Oncology position performs unexpectedly, X4 Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in X4 Pharmaceuticals will offset losses from the drop in X4 Pharmaceuticals' long position.| Elevation Oncology vs. Ocean Biomedical | Elevation Oncology vs. Zura Bio Limited | Elevation Oncology vs. Enveric Biosciences | Elevation Oncology vs. Hepion Pharmaceuticals |
| X4 Pharmaceuticals vs. Terns Pharmaceuticals | X4 Pharmaceuticals vs. Day One Biopharmaceuticals | X4 Pharmaceuticals vs. PDS Biotechnology Corp | X4 Pharmaceuticals vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Other Complementary Tools
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |